Treatment interruption after early-treated perinatal HIV-1 infection.
aMolecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA bPediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Katherine
K
Luzuriaga
Deborah
D
Persaud
D019380:Anti-HIV Agents; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections; D015497:HIV-1; D006801:Humans; D011247:Pregnancy
D019380:Anti-HIV Agents